Park Ha Biological (BYAH) investors Nexera and Jie Cao disclose 9.1% ownership stake
Rhea-AI Filing Summary
Nexera Technology Company Limited and Jie Cao report beneficial ownership of Park Ha Biological Technology Co., Ltd. Class A Ordinary Shares. Each reporting person beneficially owns 390,000 Class A Ordinary Shares, including 240,000 shares issuable upon exercise of warrants within 60 days. This represents 9.1% of the Class A Ordinary Shares, based on 2,297,902 shares outstanding following a reverse stock split effective August 6, 2026, plus 2,000,000 shares underlying a warrant that is exercisable within 60 days. Each reporting person has sole voting and dispositive power over these 390,000 shares.
Positive
- None.
Negative
- None.
Key Figures
Beneficial ownership per reporting person: 390,000 Class A Ordinary Shares
Ownership percentage: 9.1 %
Shares outstanding: 2,297,902 Class A Ordinary Shares
+2 more
5 metrics
Beneficial ownership per reporting person
390,000 Class A Ordinary Shares
Shares beneficially owned by each of Nexera Technology Company Limited and Jie Cao
Ownership percentage
9.1 %
Percent of Park Ha Class A Ordinary Shares beneficially owned by each reporting person
Shares outstanding
2,297,902 Class A Ordinary Shares
Outstanding following reverse stock split effective August 6, 2026
Warrant shares in ownership
240,000 Class A Ordinary Shares
Portion of each reporting person’s holdings issuable upon warrant exercise within 60 days
Additional warrant pool
2,000,000 Class A Ordinary Shares
Shares underlying a warrant exercisable within the next 60 days, included in base for ownership percentage
Key Terms
beneficially owned, reverse stock split, sole voting power, sole dispositive power, +1 more
5 terms
beneficially owned financial
"Amount beneficially owned: Nexera Technology Company Limited: 390,000; and Jie Cao: 390,000."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
reverse stock split financial
"Class A Ordinary Shares outstanding following the effectiveness of the reverse stock split on August 6, 2026"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
sole voting power financial
"Sole Voting Power 390,000.00 6 | Shared Voting Power 0.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power financial
"Sole Dispositive Power 390,000.00 8 | Shared Dispositive Power 0.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
FAQ
What percentage of Park Ha Biological Technology (BYAH) does Nexera Technology own?
Nexera Technology Company Limited reports beneficial ownership of 9.1% of Park Ha Biological Technology’s Class A Ordinary Shares, representing 390,000 shares, including 240,000 shares issuable upon exercise of warrants within the next 60 days.
Where are the reporting persons for Park Ha Biological Technology (BYAH) Schedule 13G based?
The principal business office of the reporting persons is in Wuxi City, Jiangsu Province, China, specifically at Room 301, No. 10 Erquan Dongyuan, as disclosed in the Schedule 13G filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.